Unlock genomic insights with DRAGEN
23 Jun 2026
Discover how breakthrough genomics innovations are reshaping healthcare and agriculture. This video spotlights the DRAGEN™ platform, delivering unmatched accuracy and speed in secondary analysis, including 99.89% germline whole‑genome small‑variant calling accuracy. See how DRAGEN accelerates genomic insights, performs complex analyses up to 10× faster than traditional methods, and helps unlock the full potential of modern genomic research.
About the company
Illumina
Innovative technologies
At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.
